CMRX - Financial Reports List - Chimerix, Inc. - IntrinsicAlpha

Chimerix, Inc. CMRX

Healthcare - Biotechnology - NASDAQ - US

$ 8.54

-0.117 %

$ 801 M

Market Cap

-8.63

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	1325.00%	-26.39%	-17.98%
Annual Report	FY	10-K	2024-12-31	-34.57%	-7.66%	-3.76%
Quarterly Report	Q3	8-K	2024-09-30	136.36%	4.62%	7.10%
Quarterly Report	Q2	8-K	2024-06-30	396.15%	-11.35%	-6.95%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-18.04%	-0.71%
Quarterly Report	Q4	8-K	2023-12-31	-99.51%	13.35%	12.61%
Annual Report	FY	10-K	2023-12-31	-99.04%	-47.68%	-54.12%
Quarterly Report	Q3	8-K	2023-09-30	-99.97%	-9.94%	-229.17%
Quarterly Report	Q2	8-K	2023-06-30	-94.09%	20.92%	8.95%
Quarterly Report	Q1	8-K	2023-03-31	1786.67%	25.19%	2.23%

1